Skip to main content

Breadcrumb

  1. Home

A Phase III, Randomised Study of Adjuvant Dato-DXd in Combination With Rilvegostomig or Rilvegostomig Monotherapy Versus Standard of Care, Following Complete Tumour Resection, in Participants With Stage I Adenocarcinoma NSCLC Who Are ctDNA-positive or Ha

Submitted by korinna@manifo… on Fri, 10/03/2025 - 16:25
  • Read more about A Phase III, Randomised Study of Adjuvant Dato-DXd in Combination With Rilvegostomig or Rilvegostomig Monotherapy Versus Standard of Care, Following Complete Tumour Resection, in Participants With Stage I Adenocarcinoma NSCLC Who Are ctDNA-positive or Ha

Study of IBI3020 Treatment in Participants With Late-Stage Solid Tumors

Submitted by ariel on Wed, 09/24/2025 - 15:29
  • Read more about Study of IBI3020 Treatment in Participants With Late-Stage Solid Tumors

Centralized Screening Unit (CSU) at Montefiore-Einstein

Submitted by Anonymous (not verified) on Thu, 09/18/2025 - 18:04
  • Read more about Centralized Screening Unit (CSU) at Montefiore-Einstein

A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)

Submitted by ariel on Thu, 09/18/2025 - 17:50
  • Read more about A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)

High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer

Submitted by ariel on Thu, 09/18/2025 - 17:50
  • Read more about High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

Submitted by ariel on Thu, 09/18/2025 - 17:50
  • Read more about Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

Study of Daraxonrasib (RMC-6236) in Previously Treated Patients With RAS Mutated NSCLC (RASolve 301)

Submitted by ariel on Thu, 09/18/2025 - 17:50
  • Read more about Study of Daraxonrasib (RMC-6236) in Previously Treated Patients With RAS Mutated NSCLC (RASolve 301)

Testing the Addition of AZD6738 (Ceralasertib) to Immunotherapy to Increase Time Without Cancer for Patients With Non-Small Cell Lung Cancer

Submitted by ariel on Thu, 09/18/2025 - 17:50
  • Read more about Testing the Addition of AZD6738 (Ceralasertib) to Immunotherapy to Increase Time Without Cancer for Patients With Non-Small Cell Lung Cancer

Safety, Effectiveness, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

Submitted by ariel on Thu, 09/18/2025 - 17:50
  • Read more about Safety, Effectiveness, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

Submitted by ariel on Thu, 09/18/2025 - 17:50
  • Read more about Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

Pagination

  • First page First
  • Previous page Previous
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Next
  • Last page Last
Subscribe to